Evidence map›Paper›PMID 37980506›Full record

ArticleBMC microbiology2023

Alterations in gut microbiota and metabolite profiles in patients with infantile cholestasis.

Meng Jin, Jinghua Cui, Huijuan Ning, Meijuan Wang, Wenwen Liu, Kunyu Yao, Jing Yuan, Xuemei Zhong

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Meng Jin *Gastroenterology Department, Children's Hospital Capital Institute of Pediatrics, Beijing, 100020, China.
Jinghua Cui *Bacteriology Department, Capital Institute of Pediatrics, Beijing, 100020, China.
Huijuan NingGastroenterology Department, Children's Hospital Capital Institute of Pediatrics, Beijing, 100020, China.
Meijuan WangGastroenterology Department, Children's Hospital Capital Institute of Pediatrics, Beijing, 100020, China.
Wenwen LiuGastroenterology Department, Children's Hospital Capital Institute of Pediatrics, Beijing, 100020, China.
Kunyu YaoGastroenterology Department, Children's Hospital Capital Institute of Pediatrics, Beijing, 100020, China.
Jing YuanBacteriology Department, Capital Institute of Pediatrics, Beijing, 100020, China. yuanjing6216@163.com.
Xuemei ZhongGastroenterology Department, Children's Hospital Capital Institute of Pediatrics, Beijing, 100020, China. zhongxuemei5566@163.com.
Children's Hospital of Capital Institute of Pediatrics · CNCapital Institute of Pediatrics · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfantile cholestasis (IC) is the most common hepatobiliary disease in infants, resulting in elevated direct bilirubin levels. Indeed, hepatointestinal circulation impacts bile acid and bilirubin metabolism. This study evaluates changes in the gut microbiota composition in children with IC and identifies abnormal metabolite profiles associated with microbial alterations.

resultsThe gut microbiota in the IC group exhibits the higher abundance of Veillonella, Streptococcus and Clostridium spp. (P < 0.05), compared to healthy infants (CON) group. Moreover, the abundance of Ruminococcus, Vibrio butyricum, Eubacterium coprostanogenes group, Intestinibacter, and Faecalibacterium were lower (P < 0.05). In terms of microbiota-derived metabolites, the levels of fatty acids (palmitoleic, α-linolenic, arachidonic, and linoleic) (P < 0.05) increased and the levels of amino acids decreased in IC group. Furthermore, the abundances of Ruminococcus, Eubacterium coprostanoligenes group, Intestinibacter and Butyrivibrio are positively correlated with proline, asparagine and aspartic acid, but negatively correlated with the α-linolenic acid, linoleic acid, palmitoleic acid and arachidonic acid. For analysis of the relationship between the microbiota and clinical index, it was found that the abundance of Veillonella and Streptococcus was positively correlated with serum bile acid content (P < 0.05), while APTT, PT and INR were negatively correlated with Faecalibalum and Ruminococcus (P < 0.05).

conclusionMicrobiota dysbiosis happened in IC children, which also can lead to the abnormal metabolism, thus obstructing the absorption of enteral nutrition and aggravating liver cell damage. Veillonella, Ruminococcus and Butyrivibrio may be important microbiome related with IC and need further research.

Indexed as

CholestasisGastrointestinal MicrobiomeBile Acids and SaltsBilirubinChildHumansInfantLiverStreptococcusBile Acids and SaltsBilirubinButyrivibrioGut microbiotaInfantile cholestasis (IC)Microbiota-derived metabolitesRuminococcusVeillonella

Identifiers

PMID37980506
PMCPMC10656868
OpenAlexW4388796115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.